DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 076962
The generic ingredient in BROMOCRIPTINE MESYLATE is bromocriptine mesylate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.
Summary for 076962
Tradename: | BROMOCRIPTINE MESYLATE |
Applicant: | Mylan |
Ingredient: | bromocriptine mesylate |
Patents: | 0 |
Therapeutic Class: | Antiparkinson Agents Hormonal Agents, Suppressant (Pituitary) |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 076962
Ingredient-type | Ergolines |
Medical Subject Heading (MeSH) Categories for 076962
Suppliers and Packaging for NDA: 076962
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 076962 | ANDA | KAISER FOUNDATION HOSPITALS | 0179-0165 | N | 0179-0165-70 |
BROMOCRIPTINE MESYLATE | bromocriptine mesylate | TABLET;ORAL | 076962 | ANDA | Mylan Pharmaceuticals Inc. | 0378-2042 | N | 0378-2042-93 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | Sep 24, 2004 | TE: | AB | RLD: | No |
Complete Access Available with Subscription